184 related articles for article (PubMed ID: 30606672)
21. Novel cyclin-dependent kinase 9 (CDK9) inhibitor with suppression of cancer stemness activity against non-small-cell lung cancer.
Wang X; Yu C; Wang C; Ma Y; Wang T; Li Y; Huang Z; Zhou M; Sun P; Zheng J; Yang S; Fan Y; Xiang R
Eur J Med Chem; 2019 Nov; 181():111535. PubMed ID: 31376566
[TBL] [Abstract][Full Text] [Related]
22. Alkylsulfanyl-1,2,4-triazoles, a new class of allosteric valosine containing protein inhibitors. Synthesis and structure-activity relationships.
Polucci P; Magnaghi P; Angiolini M; Asa D; Avanzi N; Badari A; Bertrand J; Casale E; Cauteruccio S; Cirla A; Cozzi L; Galvani A; Jackson PK; Liu Y; Magnuson S; Malgesini B; Nuvoloni S; Orrenius C; Sirtori FR; Riceputi L; Rizzi S; Trucchi B; O'Brien T; Isacchi A; Donati D; D'Alessio R
J Med Chem; 2013 Jan; 56(2):437-50. PubMed ID: 23245311
[TBL] [Abstract][Full Text] [Related]
23. A Computer - Aided Drug Designing for Pharmacological Inhibition of Mutant ALK for the Treatment of Non-small Cell Lung Cancer.
Sharda S; Khandelwal R; Adhikary R; Sharma D; Majhi M; Hussain T; Nayarisseri A; Singh SK
Curr Top Med Chem; 2019; 19(13):1129-1144. PubMed ID: 31109278
[TBL] [Abstract][Full Text] [Related]
24. Small molecule purine and pseudopurine derivatives: synthesis, cytostatic evaluations and investigation of growth inhibitory effect in non-small cell lung cancer A549.
Bistrović A; Grbčić P; Harej A; Sedić M; Kraljević-Pavelić S; Koštrun S; Plavec J; Makuc D; Raić-Malić S
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):271-285. PubMed ID: 29271659
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, in vitro and in vivo evaluation, and structure-activity relationship (SAR) discussion of novel dipeptidyl boronic acid proteasome inhibitors as orally available anti-cancer agents for the treatment of multiple myeloma and mechanism studies.
Lei M; Feng H; Bai E; Zhou H; Wang J; Shi J; Wang X; Hu S; Liu Z; Zhu Y
Bioorg Med Chem; 2018 Aug; 26(14):3975-3981. PubMed ID: 29934218
[TBL] [Abstract][Full Text] [Related]
26. Discovery of hybrid Hsp90 inhibitors and their anti-neoplastic effects against gefitinib-resistant non-small cell lung cancer (NSCLC).
Jeong CH; Park HB; Jang WJ; Jung SH; Seo YH
Bioorg Med Chem Lett; 2014 Jan; 24(1):224-7. PubMed ID: 24345447
[TBL] [Abstract][Full Text] [Related]
27. Ginsenoside metabolite compound K induces apoptosis and autophagy in non-small cell lung cancer cells via AMPK-mTOR and JNK pathways.
Li C; Dong Y; Wang L; Xu G; Yang Q; Tang X; Qiao Y; Cong Z
Biochem Cell Biol; 2019 Aug; 97(4):406-414. PubMed ID: 30475650
[TBL] [Abstract][Full Text] [Related]
28. Discovery of New Monocarbonyl Ligustrazine-Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer.
Ai Y; Zhu B; Ren C; Kang F; Li J; Huang Z; Lai Y; Peng S; Ding K; Tian J; Zhang Y
J Med Chem; 2016 Mar; 59(5):1747-60. PubMed ID: 26891099
[TBL] [Abstract][Full Text] [Related]
29. New acrylamide-substituted quinazoline derivatives with enhanced potency for the treatment of EGFR T790M-mutant non-small-cell lung cancers.
Liu Z; Wang L; Feng M; Yi Y; Zhang W; Liu W; Li L; Liu Z; Li Y; Ma X
Bioorg Chem; 2018 Apr; 77():593-599. PubMed ID: 29482151
[TBL] [Abstract][Full Text] [Related]
30. 2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).
Bursavich MG; Parker DP; Willardsen JA; Gao ZH; Davis T; Ostanin K; Robinson R; Peterson A; Cimbora DM; Zhu JF; Richards B
Bioorg Med Chem Lett; 2010 Mar; 20(5):1677-9. PubMed ID: 20137940
[TBL] [Abstract][Full Text] [Related]
31. A small-molecule ligand of valosin-containing protein/p97 inhibits cancer cell-accelerated fibroblast migration.
Suvarna K; Honda K; Muroi M; Kondoh Y; Osada H; Watanabe N
J Biol Chem; 2019 Mar; 294(9):2988-2996. PubMed ID: 30610116
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer.
Bistrović A; Krstulović L; Harej A; Grbčić P; Sedić M; Koštrun S; Pavelić SK; Bajić M; Raić-Malić S
Eur J Med Chem; 2018 Jan; 143():1616-1634. PubMed ID: 29133046
[TBL] [Abstract][Full Text] [Related]
33. Critical role of VCP/p97 in the pathogenesis and progression of non-small cell lung carcinoma.
Valle CW; Min T; Bodas M; Mazur S; Begum S; Tang D; Vij N
PLoS One; 2011; 6(12):e29073. PubMed ID: 22216170
[TBL] [Abstract][Full Text] [Related]
34. Development of an Improved Guanidine-Based Rac1 Inhibitor with in vivo Activity against Non-Small Cell Lung Cancer.
Ciarlantini MS; Barquero A; Bayo J; Wetzler D; Dodes Traian MM; Bucci HA; Fiore EJ; Gandolfi Donadío L; Defelipe L; Turjanski A; Ramírez JA; Mazzolini G; Comin MJ
ChemMedChem; 2021 Mar; 16(6):1011-1021. PubMed ID: 33284505
[TBL] [Abstract][Full Text] [Related]
35. p97: An Emerging Target for Cancer, Neurodegenerative Diseases, and Viral Infections.
Huryn DM; Kornfilt DJP; Wipf P
J Med Chem; 2020 Mar; 63(5):1892-1907. PubMed ID: 31550150
[TBL] [Abstract][Full Text] [Related]
36. Discovery of Irreversible p97 Inhibitors.
Ding R; Zhang T; Wilson DJ; Xie J; Williams J; Xu Y; Ye Y; Chen L
J Med Chem; 2019 Mar; 62(5):2814-2829. PubMed ID: 30830772
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of alkyl substituted pyridino[2,3-D]pyrimidine compounds as PI3Kα/mTOR dual inhibitors with improved pharmacokinetic properties and potent in vivo antitumor activity.
Liu Y; Xia Q; Fang L
Bioorg Med Chem; 2018 Aug; 26(14):3992-4000. PubMed ID: 29945756
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a Chiral DNA-Targeted Platinum-Acridine Agent with Potent Enantioselective Anticancer Activity.
Zhang S; Yao X; Watkins NH; Rose PK; Caruso SR; Day CS; Bierbach U
Angew Chem Int Ed Engl; 2020 Dec; 59(49):21965-21970. PubMed ID: 32835419
[TBL] [Abstract][Full Text] [Related]
39. Development of 3-methyl/3-(morpholinomethyl)benzofuran derivatives as novel antitumor agents towards non-small cell lung cancer cells.
Al-Sanea MM; Al-Ansary GH; Elsayed ZM; Maklad RM; Elkaeed EB; Abdelgawad MA; Bukhari SNA; Abdel-Aziz MM; Suliman H; Eldehna WM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):987-999. PubMed ID: 33985397
[TBL] [Abstract][Full Text] [Related]
40. Inhibitors of the ATPase p97/VCP: From basic research to clinical applications.
Kilgas S; Ramadan K
Cell Chem Biol; 2023 Jan; 30(1):3-21. PubMed ID: 36640759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
